COMPOUNDS FOR THE TREATMENT OF KINASE-DEPENDENT DISORDERS

COMPOUNDS FOR THE TREATMENT OF KINASE-DEPENDENT DISORDERS

The present disclosure relates to tyrosine kinase inhibitors of Formula I and Compound 1, or pharmaceutically acceptable salts thereof. The present disclosure further relates to processes for the preparation of the tyrosine kinase inhibitors, Formula I and Compound 1, or a pharmaceutically acceptabl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: XU, WEI, DEMORIN, FRENEL, SHAKYA, SAGAR, WANG, YONG, SHAH, KHALID
Format: Patent
Sprache:eng ; fre
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present disclosure relates to tyrosine kinase inhibitors of Formula I and Compound 1, or pharmaceutically acceptable salts thereof. The present disclosure further relates to processes for the preparation of the tyrosine kinase inhibitors, Formula I and Compound 1, or a pharmaceutically acceptable salt thereof. La présente invention concerne des inhibiteurs de tyrosine kinase de formule I et le composé 1, ou des sels pharmaceutiquement acceptables de ceux-ci. La présente invention concerne en outre des procédés de préparation des inhibiteurs de tyrosine kinase, de formule I et du composé 1, ou d'un sel pharmaceutiquement acceptable de ceux-ci.